TNMG:NASDAQTNL Mediagene Analysis
Data as of 2026-05-26 - not real-time
$0.73
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Technical outlook: TNMG trades at $0.73, well below its 20‑day ($0.81), 50‑day ($1.31) and 200‑day ($4.30) SMAs, confirming a bearish price trend. The RSI of 36.7 signals mild oversold conditions, while the MACD line sits above its signal (histogram +0.034), offering a tentative bullish hint. Volume is increasing, but the 30‑day volatility of 161.6% and a beta near 1.95 imply extreme price swings.
Fundamental and regulatory backdrop: The company’s fundamentals are deeply distressed: operating margin of –25.9%, profit margin of –167.9%, negative EBITDA of $‑48 M, and a max drawdown of –96.4%. Debt‑to‑equity is a staggering 58, with $20 M of debt against just $1.9 M cash, and a market cap of only $2.1 M. Crucially, TNMG has received a Nasdaq non‑compliance and delisting warning, elevating regulatory and liquidity risks. Despite ultra‑low valuation multiples (PB 0.053, price‑to‑sales 0.043), the financial and compliance headwinds dominate the outlook.
Fundamental and regulatory backdrop: The company’s fundamentals are deeply distressed: operating margin of –25.9%, profit margin of –167.9%, negative EBITDA of $‑48 M, and a max drawdown of –96.4%. Debt‑to‑equity is a staggering 58, with $20 M of debt against just $1.9 M cash, and a market cap of only $2.1 M. Crucially, TNMG has received a Nasdaq non‑compliance and delisting warning, elevating regulatory and liquidity risks. Despite ultra‑low valuation multiples (PB 0.053, price‑to‑sales 0.043), the financial and compliance headwinds dominate the outlook.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Nasdaq delisting warning and non‑compliance
- Price trading near support with bearish SMA alignment
- Severe financial distress and negative cash flows
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential resolution of compliance issues
- Extremely low valuation may attract speculative buying
- Continued volatility and weak fundamentals limit upside
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Persistent negative earnings and cash flow
- High debt load relative to tiny market cap
- Regulatory risk of delisting likely erodes shareholder value
Key Metrics & Analysis
Financial Health
Revenue Growth5.70%
Profit Margin-167.90%
P/E Ratio-5.2
ROE-164.59%
ROA-31.70%
Debt/Equity58.06
P/B Ratio0.1
Op. Cash Flow$-11133360
Free Cash Flow$-24020994
Industry P/E17.0
Technical Analysis
TrendBearish
RSI36.7
Support$0.56
Resistance$1.12
MA 20$0.81
MA 50$1.31
MA 200$4.30
MACDBullish
VolumeIncreasing
Fear & Greed Index90.91
Valuation
Target Price$14.00
Upside/Downside1817.81%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.95
Volatility161.61%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.